指南与共识术前评估与围术期医学

门诊手术成人糖尿病患者围术期血糖管理:SAMBA更新共识声明

Society for Ambulatory Anesthesia Updated Consensus Statement on Perioperative Blood Glucose Management in Adult Patients With Diabetes Mellitus Undergoing Ambulatory Surgery.
指南 / 共识 · Anesth Analg · 2024-03-22

该共识由门诊麻醉学会(SAMBA)专家工作组制定,基于1980至2022年文献综述更新2010版共识。推荐涵盖门诊手术糖尿病患者的术前评估、口服降糖药与家庭胰岛素管理、术中检测与处理、以及麻醉后监护室和术后回家过渡期的血糖管理。高质量证据仍 sparse,推荐基于近期指南、住院手术数据、药物药理学及新兴治疗数据。

要点

  • 更新2010版SAMBA共识,纳入新型降糖药、胰岛素泵和持续血糖监测等新干预。
  • 推荐覆盖术前评估、术前口服降糖药和家庭胰岛素调整、术中检测与治疗、PACU及术后过渡期管理。
  • 门诊手术糖尿病患者围术期血糖管理的高质量证据仍 sparse,推荐基于现有文献和指南。

核心结论

  • SAMBA更新共识为成人糖尿病患者门诊手术围术期血糖管理提供推荐,涵盖术前至术后过渡全流程。

研究设计与样本

  • 由SAMBA专家工作组制定,基于1980至2022年文献综合综述,成员包括该领域专家及原始文献贡献者。

主要发现

  • 自2010年共识以来出现新型降糖药、胰岛素泵和持续血糖监测等新干预,共识修订过时问题并新增相关临床问题。
  • 门诊手术糖尿病患者围术期血糖管理的高质量证据仍 sparse,推荐基于近期指南、住院手术人群数据、药物药理学及新兴治疗数据。

关键数值与推荐

  • 推荐涵盖术前评估、术前口服降糖药和家庭胰岛素管理、术中检测与治疗方式、以及麻醉后监护室和术后回家过渡期的血糖管理。
  • 推荐制定时考虑干预措施的利益与风险及临床实践信息,以确保患者安全且在门诊环境中临床有效实用。

临床怎么用

  • 麻醉科医生可依据该共识对门诊手术成人糖尿病患者进行术前评估、调整口服降糖药和家庭胰岛素、实施术中血糖检测与处理,并管理PACU及术后回家过渡期血糖。

局限性

  • 门诊手术糖尿病患者围术期血糖管理的高质量证据仍 sparse,推荐多基于近期指南、住院手术数据、药物药理学和新兴治疗数据。
  • 共识识别了需进一步研究的领域。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This consensus statement is a comprehensive update of the 2010 Society for Ambulatory Anesthesia (SAMBA) Consensus Statement on perioperative blood glucose management in patients with diabetes mellitus (DM) undergoing ambulatory surgery. Since the original consensus guidelines in 2010, several novel therapeutic interventions have been introduced to treat DM, including new hypoglycemic agents and increasing prevalence of insulin pumps and continuous glucose monitors. The updated recommendations were developed by an expert task force under the provision of SAMBA and are based on a comprehensive review of the literature from 1980 to 2022. The task force included SAMBA members with expertise on this topic and those contributing to the primary literature regarding the management of DM in the perioperative period. The recommendations encompass preoperative evaluation of patients with DM presenting for ambulatory surgery, management of preoperative oral hypoglycemic agents and home insulins, intraoperative testing and treatment modalities, and blood glucose management in the postanesthesia care unit and transition to home after surgery. High-quality evidence pertaining to perioperative blood glucose management in patients with DM undergoing ambulatory surgery remains sparse. Recommendations are therefore based on recent guidelines and available literature, including general glucose management in patients with DM, data from inpatient surgical populations, drug pharmacology, and emerging treatment data. Areas in need of further research are also identified. Importantly, the benefits and risks of interventions and clinical practice information were considered to ensure that the recommendations maintain patient safety and are clinically valid and useful in the ambulatory setting. What Other Guidelines Are Available on This Topic? Since the publication of the SAMBA Consensus Statement for perioperative blood glucose management in the ambulatory setting in 2010, several recent guidelines have been issued by the American Diabetes Association (ADA), the American Association of Clinical Endocrinologists (AACE), the Endocrine Society, the Centre for Perioperative Care (CPOC), and the Association of Anaesthetists of Great Britain and Ireland (AAGBI) on DM care in hospitalized patients; however, none are specific to ambulatory surgery. How Does This Guideline Differ From the Previous Guidelines? Previously posed clinical questions that were outdated were revised to reflect current clinical practice. Additional questions were developed relating to the perioperative management of patients with DM to include the newer therapeutic interventions.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Rajan N, Duggan EW, Abdelmalak BB, et al. Society for Ambulatory Anesthesia Updated Consensus Statement on Perioperative Blood Glucose Management in Adult Patients With Diabetes Mellitus Undergoing Ambulatory Surgery. Anesth Analg. 2024. PMID: 38517760. doi:10.1213/ANE.0000000000006791

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。